Covestor LTD Haemonetics Corp Transaction History

Covestor LTD

$150 Million
Q1 2025

A detailed history of Covestor LTD transactions in Haemonetics Corp stock. As of the latest transaction made, Covestor LTD holds 550 shares of HAE stock, worth $41,723. This represents 0.02% of its overall portfolio holdings.

Number of Shares

550

Previous 738 25.47%

Holding current value

$41,723

Previous $58,000 39.66%

% of portfolio

0.02%

Previous 0.04%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 12, 2025	SELL	$59.34 - $80.05 $11,155 - $15,049	-188 Reduced 25.47%	550 $35,000
Q4 2024 Feb 13, 2025	BUY	$71.16 - $93.38 $31,239 - $40,993	439 Added 146.82%	738 $58,000
Q3 2024 Nov 01, 2024	SELL	$72.45 - $91.58 $5,506 - $6,960	-76 Reduced 20.27%	299 $24,000
Q2 2024 Aug 09, 2024	SELL	$81.24 - $97.37 $24,372 - $29,211	-300 Reduced 44.44%	375 $31,000
Q1 2024 May 10, 2024	BUY	$71.24 - $85.35 $31,203 - $37,383	438 Added 184.81%	675 $58,000
Q4 2023 Feb 09, 2024	SELL	$80.59 - $92.61 $13,216 - $15,188	-164 Reduced 40.9%	237 $20,000
Q3 2023 Nov 13, 2023	SELL	$82.56 - $93.49 $82 - $93	-1 Reduced 0.25%	401 $36,000
Q2 2023 Aug 11, 2023	SELL	$80.84 - $89.45 $161 - $178	-2 Reduced 0.5%	402 $34,000
Q1 2023 May 15, 2023	BUY	$72.75 - $90.6 $21,897 - $27,270	301 Added 292.23%	404 $33,000
Q4 2022 Feb 13, 2023	BUY	$73.85 - $86.14 $7,311 - $8,527	99 Added 2475.0%	103 $8,000
Q3 2022 Nov 14, 2022	SELL	$63.3 - $78.66 $126 - $157	-2 Reduced 33.33%	4 $0
Q2 2022 Aug 10, 2022	SELL	$49.27 - $66.08 $98 - $132	-2 Reduced 25.0%	6 $0
Q1 2022 May 13, 2022	SELL	$43.77 - $63.22 $87 - $126	-2 Reduced 20.0%	8 $1,000
Q4 2021 Feb 10, 2022	BUY	$49.55 - $74.59 $495 - $745	10 New	10 $1,000

Others Institutions Holding HAE

# of Institutions

350

Shares Held

53.2M

Call Options Held

417K

Put Options Held

314K

View Full List

About HAEMONETICS CORP

Ticker HAE
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 51,316,500
Market Cap $3.89B
Description
Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...

More about HAE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Covestor LTD, based on Form 13F filings with the SEC.

News

Stay updated on Covestor LTD with notifications on news.

Account